Ultragenyx Pharmaceutical | Pasivo Circulante

Precio De Mercado
23.39
Cambio Diario
0.35 1.52%
Mensual
-4.30%
Anual
-45.50%
Q1 Expectativa
22.67




Pasivo Circulante Cambio Fecha
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Immunic USD 30.08M 2.77M 2025-09
Insmed USD 468.87M 51.66M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Kyowa Hakko Kirin JPY 181.08B 4.08B 2025-12
MacroGenics USD 44.47M 5.47M 2025-09
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xoma USD 28.3M 6.81M 2025-09


Ultragenyx Pharmaceutical Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.